Volume Spike Investor

Sequenom Inc. (NASDAQ: SQNM) is trading higher on an analyst call this morning. The stock was raised to “Hold” at Auriga and the target was raised to $4.00 from (prior was a Sell rating and $3.00 target).  The call noted: Based on the analysis of Sequenom’s molecular diagnostics segment (excluding the Trisomy 21-related tests that are still under regulatory cloud) centered around its recently launched Cystic fibrosis carrier screening test and upcoming launches of fetal RhD gentotyping and fetal sex determination tests, we are changing our rating on the shares of Sequenom….. At 8:20 AM EST we have shares trading up 6.2% at $4.63 on over 165,000 shares.  As a reminder, this stock has a MASSIVE short interest: 19.4 million shares, about 32% of its float.

JON C. OGG